Horizon: new medical necessity requirements for infused drug products

Effective May 1, 2022, Magellan Rx Management will include dosage considerations when performing prior authorization/medical necessity determination reviews of several infused drug products that are to be provided to members enrolled in fully insured plans.

You need to be logged in to view the rest of the content. Please . Not a Member? Join Us